R/Pharma Summit @ Posit Conf 2024, August 11th
Slides: 🔗 bit.ly/PositConf24
On behalf of the R Validation Hub team:
Aaron Clark Arcus Biosciences
Doug Kelkhoff Roche
The R Validation Hub is a collaboration to support the adoption of R within a biopharmaceutical regulatory setting (pharmaR.org)
Works with and provides support to the R Foundation and to the key organizations developing, maintaining, distributing and using R software
Over USD $1.4 Million
R Validation Hub, R-Ladies
Stanford Data Institute
R/Medicine, R/Pharma, useR!, LatinR, and more
Guidance on compliant use of R and management of packages
Building a public, validation-ready resource for R packages
Coline Zeballos
Connecting validation experts across the industry
Jaxon Abercrombie, Anuja Das, Antal Martinecz
{riskmetric}Gather and report on risk heuristics to support validation decision-making
Eric Milliman
{riskassessment}A web interface to {riskmetric}, supporting review, annotation and cataloging of decisions
Aaron Clark, Jeff Thompson
Keep your hand raised if…
{riskmetric}, {riskassessment}){riskassessment} App Workstream 7min{riskmetric} workstream 7min🗓️ Tues, Aug 20, 2024
👩🦰 Bríd Roberts
⌨️ Novartis
The Software Open Source (SOS) team manages and executes the risk assessment process for R package validation at Novartis. The team uses an internally developed R package to classify the risk of each package as “low”, “medium”, or “high”.
We analysed the risk assessment data over two time points to determine the impact on the assigned risk categorisation for packages with AND without version changes.
In this talk, we showcase the risk assessments over time, the causes of any risk class changes, and their impact on various teams within our organizations as a result.
pharmaR.org THENpharmaR.org NOWpharmaR.org to Sign Up{riskassessment} App{riskassessment} AppFunction Explorer for (1) source code, (2) help docs, and (3) tests{shinymanager} deployment options'About' tab